Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski*, Bridget Anne Kirwan, AFFIRM-AHF investigators, Stefan D. Anker, Theresa McDonagh, Maria Dorobantu, Jarosław Drozdz, Vincent Fabien, Gerasimos Filippatos, Udo Michael Göhring, Andre Keren, Irakli Khintibidze, Hans Kragten, Felipe A. Martinez, Marco Metra, Davor Milicic, José C. Nicolau, Marcus Ohlsson, Alexander Parkhomenko, Domingo A. Pascual-FigalFrank Ruschitzka, David Sim, Hadi Skouri, P. van der Meer, Basil S. Lewis, Josep Comin-Colet, Stephan von Haehling, Alain Cohen-Solal, Nicolas Danchin, Wolfram Doehner, Henry J. Dargie, Michael Motro, Javed Butler, Tim Friede, Klaus H. Jensen, Stuart Pocock, Ewa A. Jankowska

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

463 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science